Profile of Luspatercept in the Treatment of Anemia in Adults with Non-Transfusion-Dependent β-Thalassemia (NTDT): Design, Development and Potential Place in Therapy

Over the past decade, evidence has been mounting on the detrimental clinical sequelae of untreated anemia in patients with non-transfusion-dependent β-thalassemia (NTDT). There are no pharmacologic agents that are specifically approved for the management of anemia in NTDT, and available options such...

Descripción completa

Detalles Bibliográficos
Autores principales: Musallam, Khaled M, Taher, Ali T, Kattamis, Antonis, Kuo, Kevin H M, Sheth, Sujit, Cappellini, Maria Domenica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10226484/
https://www.ncbi.nlm.nih.gov/pubmed/37255740
http://dx.doi.org/10.2147/DDDT.S368584

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10226484/
https://www.ncbi.nlm.nih.gov/pubmed/37255740
http://dx.doi.org/10.2147/DDDT.S368584

Ejemplares similares